The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts

Oncogene
T Takahashi, M Shibuya

Abstract

KDR/Flk-1 tyrosine kinase, one of the two receptors for Vascular Endothelial Growth Factor (VEGF) has been shown to generate the major part of mitotic signals in endothelial cells, although the mechanisms are poorly understood. Here we examined the processing and signal transduction of KDR/Flk-1. Both in endothelial cells and in NIH3T3 cells expressing KDR/Flk-1, an immature form of KDR/Flk-1 with a molecular mass of about 150 kDa was glycosylated to create a 200 kDa intermediate, and after further glycosylation a mature 230 kDa was expressed on the cell surface. Only this 230 kDa form was rapidly and transiently phosphorylated on tyrosine residues in the presence of VEGF. As a major substrate of KDR/Flk-1, PLC-gamma was found to be rapidly tyrosine-phosphorylated and associated with KDR/Flk-1 both in endothelial cells and NIH3T3 cells. Interestingly, however, a prompt activation of MAP kinase and subsequent strong mitotic signaling were generated only in the endothelial cell background. Activation of MAP kinase in NIH3T3 cells overexpressing KDR/Flk-1 showed a slower response as maximum levels were only attained after 20 min compared to 5 min in sinusoidal endothelial cells. These results suggest that the KDR/Flk-1 utilizes ce...Continue Reading

Citations

May 11, 1999·Journal of Neurobiology·F L WatsonR A Segal
Oct 12, 2001·Microscopy Research and Technique·T A Partanen, K Paavonen
Oct 31, 2009·Targeted Oncology·Ronan J Kelly, Olivier Rixe
Apr 3, 2001·Trends in Pharmacological Sciences·M J Cross, L Claesson-Welsh
Oct 5, 2001·Cellular Signalling·N ItoL Claesson-Welsh
Feb 28, 2004·Trends in Cardiovascular Medicine·M Clauss
Apr 20, 2001·The International Journal of Biochemistry & Cell Biology·K HuangL Claesson-Welsh
Apr 20, 2001·The International Journal of Biochemistry & Cell Biology·M Shibuya
Mar 25, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Alexandra GiatromanolakiUNKNOWN Tumour and Angiogenesis Research Group
May 30, 2009·The Journal of Biological Chemistry·Jian Hua QiBela Anand-Apte
Sep 22, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hironori UeharaBalamurali K Ambati
Mar 16, 2002·The Cancer Journal·Vinay K GuptaRalph R Weichselbaum
Jul 1, 2009·Molecular and Cellular Biology·Antonietta Rosella FarinaAndrew Reay Mackay
Mar 8, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Christian Rask-Madsen, George L King
Apr 19, 2012·Blood·Lucia NapioneFederico Bussolino
May 10, 2001·Cell Structure and Function·M Shibuya
Dec 4, 2003·Biological & Pharmaceutical Bulletin·Sei-Joon JeongTomofumi Miyamoto
Sep 18, 2012·PloS One·Princess I Imoukhuede, Aleksander S Popel
Sep 28, 2013·PloS One·Catherine Czeisler, Takashi Mikawa
Jul 10, 2010·OncoTargets and Therapy·Argirios Moustakas, Teri N Kreisl
Apr 25, 2000·Drugs·H H Sedlacek
Nov 13, 2008·Journal of Cardiovascular Medicine·Ugo TestaGian Luigi Condorelli
Mar 13, 2014·Journal of Molecular Cell Biology·Annalisa ZecchinMauro Giacca
Jan 13, 2005·Proceedings of the National Academy of Sciences of the United States of America·Yoshiko SakuraiMasabumi Shibuya
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·S HiratsukaM Shibuya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.